Moody’s assigns ‘Aa3’ to University of Pennsylvania Health System

Moody’s Investors Service assigned its “Aa3” rating to Philadelphia-based University of Pennsylvania Health System’s proposed $200 million series 2017 taxable bonds as well as its proposed $400 million series A of 2017 revenue bonds.

Advertisement

At the same time, Moody’s affirmed the “Aa3” rating on UPHS’ outstanding bonds.

The affirmation is a result of several factors, including the health system’s strong market position, favorable reputation, close affiliation with the University of Pennsylvania and healthy liquidity. Moody’s also acknowledged UPHS’ limited debt burden and effective management of capital spending.

The outlook is stable, reflecting Moody’s expectation that UPHS will maintain solid operating margins to absorb some of the decline in liquidity as construction projects progress.  

More articles on healthcare finance:
Why Harvard’s $37B endowment is at risk of mediocrity
12 hospitals seeking RCM talent
Irving family presents record $700M bequest to NewYork-Presbyterian, Columbia University

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.